Tal Danino

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Spatial Control of Bacteria Using Screen Printing.

Advances in bacterial cancer therapies using synthetic biology.

Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coli.

Rapid screening of engineered microbial therapies in a 3D multicellular model.

Programmable bacteria induce durable tumor regression and systemic antitumor immunity.

Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies.

Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases.

Engineered Bacterial Production of Volatile Methyl Salicylate.

Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion.

Engineering bacteria for cancer therapy.

Enhancing the tropism of bacteria via genetically programmed biosensors.

The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.

CAR-T cells SEAK help from enzymes.

Bacterial couriers as cancer vaccines.

Reimagining cancer research with art.

A programmable encapsulation system improves delivery of therapeutic bacteria in mice.

A rapid screening platform to coculture bacteria within tumor spheroids.

Engineering bacteria as interactive cancer therapies.

Assessing chemotherapy dosing strategies in a spatial cell culture model.

Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer.

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity.

Engineered Bacteria for Short-Chain-Fatty-Acid-Repressed Expression of Biotherapeutic Molecules.

Engineered bacterial swarm patterns as spatial records of environmental inputs.

Probiotic-guided CAR-T cells for solid tumor targeting.

Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies.

Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia.